PanTher Therapeutics

company

About

PanTher Therapeutics features treatment platform designed to enhance therapeutic response with minimal side effects.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$5.41M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.41M
PanTher Therapeutics has raised a total of $5.41M in funding over 2 rounds. Their latest funding was raised on May 19, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 19, 2021 Series A $5.41M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
PanTher Therapeutics is funded by 1 investors. Angel Physicians Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Angel Physicians Fund Series A